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Abstract
BACKGROUND—29% of women aged 30-39 report having had a mammogram though
sensitivity and specificity are low. We investigate racial/ethnic differences in future
mammography behavior among women who had a baseline screening mammogram prior to age
40.
METHODS—Using 1994-2008 data from the Breast Cancer Surveillance Consortium (BCSC),
we identified 29,390 women ages 35-39 with a baseline screening mammogram. We followed this
cohort for two outcomes: (1) future BCSC mammography between ages 40-45; and (2) among
those, delay in screening mammography until ages 43-45 compared to 40-42. Using adjusted log-
linear models, we estimated the relative risk (RR) of these outcomes by race/ethnicity, while also
considering the impact of false positive/true negative (FP/TN) baseline mammography results on
these outcomes.
RESULTS—Relative to non-Hispanic white women, Hispanic women had an increased risk of no
future BCSC mammography (RR: 1.21, 95% confidence interval (CI): 1.13-1.30); Asian women
had a decreased risk (RR: 0.67, 95% CI: 0.61-0.74). Women with a FP, compared to TN, had a
decreased risk of no future BCSC mammography (RR: 0.89, 95% CI: 0.85-0.95). Among those
with future BCSC screening mammography, African American women were more likely to delay
the timing (RR: 1.26, 95% CI: 1.09-1.45). The interaction between race/ethnicity and FP/TN
baseline results was not significant.
CONCLUSIONS—Race/ethnicity is differentially associated with future BCSC mammography
and the timing of screening mammography after age 40.
IMPACT—These findings introduce the need for research that examines disparities in lifetime
mammography use patterns from the initiation of mammography screening.
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Guidelines for the age at which to begin breast cancer screening have evolved over the last
few decades and have at times conflicted across major organizations. In 1989, the U.S.
Preventive Services Task Force (USPSTF) recommended mammography for women
beginning at age 50.(1) They discouraged “baseline” mammograms before 50; however,
suggested it may be prudent to begin regular mammography earlier (e.g. age 35) for women
at high risk because of family history.(1) In 1996, the USPSTF suggested insufficient
evidence for or against mammography screening for women under age 50.(2) In 2002, their
guidelines recommended mammography screening every 1-2 years beginning at age 40.(3)
Most recently,(4) the USPSTF suggested that beginning regular, biennial screening
mammography before 50 is an individual decision. In contrast, the American Cancer Society
(ACS) guidelines have recommended a baseline mammogram for women between ages
35-39,(5) and since 1992, have recommended regular screening begin at age 40.(5,6)
Yet in 2005 when the age at which to begin routine screening was generally recommended
as 40, one population-based study estimated 29% of U.S. women ages 30-39 reported
having had a mammogram; this percentage was even higher among non-Hispanic African
American (AA) women (34%).(7) Among women younger than 40 (which we refer to here
as “younger women”) who had a mammogram, 74% were reported to be for screening
purposes; of those, only 13% reported a family history.(8) Among AA women, 40%
reported the age at their first mammogram as <40 years,(9) and AA women were more
likely than white women to report multiple mammograms before age 40.(7)
In contrast, after age 40 AA and Asian women are less likely to receive adequate
mammography screening(10). Racial/ethnic variation in mammography use patterns before
and after age 40 may reflect different subgroups of women. Alternatively, it is as yet
unknown whether racial/ethnic variation exists in longitudinal mammography use patterns
when following a cohort of women between early and later mammography use.
One important consideration in addressing screening mammography for younger women is
the implications of poor mammography performance. A recent study estimated that a
population of 10,000 women ages 35-39 undergoing a first screening mammogram would
produce 1,266 further work-ups, detect 16 cancers, and produce 1,250 false positive (FP)
results.(11) A related study of women with first mammograms younger than 40 reported one
FP result for every eight screening mammograms, and that AA women were more likely
than white women to be recommended for additional workup.(8) In a sample of women of
all ages who underwent mammography, only 80% of AA and 71% of Hispanic women
reported being likely or very likely to continue screening mammography after receiving FP
results, compared to 93% of white women;(12) however, responses in the latter study were
based on hypothetical questions, and not actual screening behaviors. Reports of the impact
of FP mammograms suggest an increase in patients’ anxiety or psychological difficulty, but
not a decreased adherence to further screening.(13-18) However, a common limitation
among these studies is that they did not examine the impact by race/ethnicity.
The data available to longitudinally examine the association between race/ethnicity and later
(after age 40) mammography, among women with early (younger than age 40)
mammography, while incorporating mammography type (screening versus diagnostic) and
outcomes (e.g. FP results) is extremely limited. The National Cancer Institute’s Breast
Cancer Surveillance Consortium(19) (BCSC) data are rich in their racial/ethnic diversity and
ability to prospectively follow women over time. Using a defined cohort of women who had
a first screening mammogram between ages 35-39 (referred to here as a “baseline
mammogram”), our objective was to examine the relationship between race/ethnicity and
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mammography use after age 40. Our primary hypothesis is that race/ethnicity will be
differentially associated with future mammography use among women who had a baseline
screening mammogram before age 40. Our secondary hypothesis is that these results will be
modified by FP baseline mammography results.
METHODS
Data Sources
Data were pooled from the National Cancer Institute’s Breast Cancer Surveillance
Consortium (BCSC), a collaborative network of community-based mammography registries
created for the purpose of assessing the delivery and quality of breast cancer mammography
utilization and outcomes in the United States. The seven registries are located across the
U.S. in North Carolina, Washington, New Hampshire, New Mexico, California, Colorado,
and Vermont. A Statistical Coordinating Center (SCC) oversees the coordination, pooling,
and cleaning of data from the seven sites. Each registry and the SCC have received
Institutional Review Board (IRB) approval for either active or passive consenting processes
or a waiver of consent to enroll participants, link data, and perform analytic studies. All
procedures are Health Insurance Portability and Accountability Act (HIPAA) compliant and
all registries and the SCC have received a Federal Certificate of Confidentiality and other
protection for the identities of women, physicians, and facilities who are subjects of this
research. The University of Missouri’s Health Sciences IRB approved this study as exempt.
The BCSC data are collected prospectively at the time of each screening visit, from the
patient, technologists and radiologists. Participating radiology practices gather information
from women at each breast imaging visit via a patient history form, including: age; race;
ethnicity; education; history of breast procedures; and personal and first degree family
history of breast cancer. The radiologists and/or technologists record information on the
imaging studies, including mammography indication (screening or diagnostic). Each registry
annually links to a state tumor registry or regional Surveillance, Epidemiology, and End
Results program that collects population-based cancer data; some registries also link to
pathology databases. The BCSC registries are described in greater detail elsewhere.(19)
Study Sample
As noted earlier, in 2002 both the USPSTF and ACS were recommending mammography
screening begin at age 40. Therefore, we identified 32,670 women ages 35-39 with early
mammography, whose first mammogram was for screening and was captured in the BCSC
data between the years 1994-2002 (see Figure 1). As our study required sufficient follow-up
time to have the ability to observe these women returning to a BCSC facility for future
mammography between ages 40-45, we chose years 1994-2002 in order to only include
women who would have had the potential to turn age 45 before the end of our observation
time in the BCSC data. The end of our observation time was based on mammography
completeness dates for each of the BCSC registries, which was through 2008. Additional
eligibility criteria for our analysis included no personal history of breast cancer, breast
mastectomy, or breast augmentation.
Self-reported information was used to create mutually exclusive categories of race/ethnicity:
non-Hispanic African American, non-Hispanic white, Asian, and Hispanic. For brevity, we
refer to these as AA, white, Asian, and Hispanic. We excluded 3,205 (9.8%) women who
were either missing self-reported race/ethnicity or reported a race/ethnicity not in the above
four categories due to the difficulty in deriving a meaningful interpretation from this
heterogeneous group. We additionally excluded 75 women who received a cancer diagnosis
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within the year following their baseline screening examination. The final study sample
consisted of 29,390 women.
Measurements and Definitions
The BCSC has previously addressed complex issues of variable definitions,(20,21) which
we adopt here together with standard definitions based on the Breast Imaging Reporting and
Data System® (BI-RADS).(22) We defined a screening mammogram as a mammography
examination with bilateral routine views taken with no other radiologic breast imaging
within the prior nine months, and where the radiologist or technologist indicated the
mammogram was for screening purposes. Radiologists interpreted the screening
mammograms according to the ACR BI-RADS coding system, assigning a 0 or 1-6 to each
breast, and provided a recommendation for follow-up action. Based on the most severe
assessment and the follow-up recommendations, we defined a positive assessment as BI-
RADS category 4, 5, 0, or 3 with a recommendation for immediate follow-up. We defined a
negative assessment as BI-RADS category 1, 2, or 3 with no recommendation for immediate
follow-up. A woman was considered to have breast cancer if she was diagnosed with
invasive carcinoma or ductal carcinoma in situ within the 12 months following the screening
mammogram and before her next screening exam. For women who did not receive a breast
cancer diagnosis, a screening mammogram was considered a TN if the radiologist provided
a negative assessment, and a FP if the radiologist provided a positive assessment.(21)
For this study, we defined a “baseline” screening mammogram as a woman’s first screening
mammogram between ages 35-39. To qualify as a baseline mammogram, the BCSC
database could have no record of prior mammography, no indication of comparison films,
and no self-report of prior mammography from the woman. We considered baseline
mammography outcomes for our secondary hypothesis because health behaviors and
perspectives would not be contaminated by previous mammography outcomes at that time.
Rural or urban status was based on a classification scheme using a woman’s reported
zipcode at the time of her baseline mammogram, the standard Bureau of Census Urbanized
Area and Urban Clusters definitions, and the 2000 Census work commuting information.
(23)
We examined two outcomes by race/ethnicity. First, among the 29,390 women in our study
sample, we examined whether or not a woman returned to one of the BCSC facilities for any
type of mammogram (screening, diagnostic, or unknown) between ages 40-45 (defined as
“future BCSC mammography”) (Figure 1). Second, among the 20,192 women who had
future BCSC mammography, we assessed delay in the timing of the first “future screening
mammogram” between ages 40-45. This was not necessarily her next screening
mammogram after baseline; she may have had additional mammography between baseline
and age 40 (see Statistical Analyses). We defined a delay as having a routine screening
mammogram between ages 43-45 compared to 40-42, given the recommended interval of
1-2 years. Women whose first mammogram between ages 40-45 was for diagnostic or
unknown purposes were excluded from this second outcome, as were 78 women who
developed breast cancer between baseline and their first age 40-45 mammogram, leaving a
total of 18,047 women for the second analysis.
Statistical Analyses
We characterize our sample at the time of the baseline mammogram using frequencies and
percentages, overall and by whether the women had future BCSC mammography between
ages 40-45. We further describe the sample of women with future BCSC mammography, by
race/ethnicity and FP/TN baseline results.
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We fit a series of log-linear models to estimate the relative risk (RR) of each of our two
outcomes with race/ethnicity and the baseline mammogram result (FP or TN). Next, we
added, in sequence, each of the following covariables as potential mediators to observe any
changes in our RR’s of interest: mammography registry, age at baseline screening
mammogram, rural/urban residential status at the time of baseline screening, and additional
screening mammography prior to age 40.
We examined education and first-degree family history (yes versus other) as potential
mediating factors; however, given the large percentage of missing data for those covariables,
we considered this a sensitivity analysis (and reported it as such) and thus did not include
those terms in the final presented model.
We considered effect modification between race/ethnicity and outcome of the baseline
mammogram (FP or TN) by including interaction terms into each of the log-linear models.
All analyses were run using SAS V9.2 (Cary, NC).
RESULTS
Overall, 22.1% of the 29,390 women in our study sample were non-white (Table 1). The
largest proportion (44.6%) of our study sample was college educated, most (70.1%) resided
in an urban area, and 45.2% had a baseline screening mammogram between ages 35-37
(mean age at baseline=37.5). Only 9.9% reported a first-degree family history of breast
cancer. At this baseline screen, 11.4% had a FP result; 21.2% had more than one
mammogram before age 40 [subjects with additional screening beyond baseline (n=3,712)
or diagnostic beyond baseline (n=3,079) but before 40].
Overall, 31.3% did not have future BCSC mammography between ages 40-45. Compared to
women who did, women who did not have future BCSC mammography were more likely at
their baseline mammogram to be: younger, AA, live in an urban area, and have a TN
baseline result. Women who did not have future BCSC mammography were more likely to
have only had one mammogram (their baseline mammogram) at a BCSC facility prior to age
40. Conversely, a greater percentage of women with future BCSC mammography between
ages 40-45 tended to be Asian and college educated.
Characteristics of the women with future BCSC mammography between ages 40-45 are
presented in Table 2. Overall, there was a mean of 40.6 months between the baseline and
follow up mammograms, with 13.1% of the women having had their first post-40 follow up
screening mammogram delayed, i.e. ages 43-45; this was higher among AA (15.1%) and
Hispanic (17.2%) women compared to white (12.6%) and Asian (13.3%) women. AA and
Hispanic women in this sample were much less likely to be college graduates. Hispanic
women were more likely to be older at baseline (ages 38-39) and less likely to have
additional screens prior to age 40. AA women were more likely to have a breast cancer
family history. Asian women were much more likely to reside in Urban areas, be older at
baseline, and were much less likely to have additional screens prior to age 40. When
considering baseline mammography results, the proportion of women having had their first
post-40 follow up screening mammogram delayed was lower among those with a FP
(10.6%) compared to TN (13.4%). Women with a FP were more likely to have a breast
cancer family history and were more likely to have undergone additional screening between
baseline and age 40. Overall, 25.1% of the sample had two or more mammograms (of any
type) before age 40; this was significantly higher for women with a baseline FP (68.1%) as
would be expected.
In our log-linear models for both not having future BCSC mammography between ages
40-45, and delayed age among those who did, the interactions between race/ethnicity and
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baseline mammography outcome were not significant (p>0.1 for all models). Therefore, we
report the main effects models in Table 3, adjusting for mammography registry, age at
baseline screening mammogram, rural/urban residential status at the time of baseline
screening, and additional screening mammography prior to age 40.
After adjusting for the above covariables, Hispanic women, compared to white women, were
at increased risk (RR=1.21; 95% CI: 1.13-1.30) of not having future BCSC mammography.
The risk was significantly decreased for Asian women (RR=0.67; 95% CI: 0.61-0.74), and
there was no significant difference for AA compared to white women (RR=1.04; 95% CI:
0.98-1.09). The risk of not having future BCSC mammography was significantly decreased
for having a baseline mammography result of FP compared to TN (RR=0.89; 95% CI:
0.85-0.95). The point estimates in our models did not vary substantially with the addition of
each potentially mediating covariable; with the exception of the model with education.
Adding education to our main model moderately attenuated the RRs comparing Asian and
Hispanics to white women [(RR: 0.79, 95% CI: 0.70-0.89) for Asian women; (RR: 1.17,
95% CI: 1.06-1.28) for Hispanic women].
Among those having future BCSC mammography specifically for screening mammography
between ages 40-45, we modeled the risk of delay in the timing of the first future screening
mammogram between ages 40-45. After adjusting for covariates, the risk of having delayed
future screening was not significantly different for Asian or Hispanic women compared to
white women. AA compared to white women had a significantly increased risk of delay
(ages 43-45 compared to 40-42) in the age of their future screening mammogram (RR=1.26;
95% CI: 1.09-1.45). There was no significant difference found for a FP compared to TN
baseline result (RR: 0.97, 95% CI: 0.85-1.10). The point estimates in our model of delay in
the timing of future screening did not vary substantially with the addition of each covariable,
with the exception of the model with education [(RR: 0.79, 95% CI: 0.66-0.96) for Asian
women; (RR: 1.03, 95% CI: 0.83-1.26) for Hispanic women].
DISCUSSION
Our study has important findings related to racial/ethnic disparities among women who
begin mammography screening before age 40. About a third of our sample did not return to
a BCSC facility for mammography between ages 40-45. Risk of not having future BCSC
mammography was greater among Hispanic women, while Asian women were more likely
to return to a BCSC facility.
Others have reported that non-white group members are less likely than non-Hispanic whites
to have a regular site of care,(24) and certain Latino subgroups are less likely to have a usual
source of care than non-Latino whites.(25) Women with both a usual place of care and usual
provider have almost five times the odds of having had a mammogram in the past year
compared with women who had no usual place;(26) not having a physician recommendation
is one of the strongest reasons women do not undergo testing.(27) Therefore, it is possible
that the Hispanic women in our sample were less likely to have a usual provider, although
we cannot determine that directly from these data. As our data only include women who
have had a mammogram, this suggests some means of access to health care. Further
investigation of access, such as examination of insurance information, is unfortunately
limited and inconsistent in these data. A post-hoc examination of our data revealed that of
the 9,198 women who did not have future BCSC mammography, 4,692 (51.0%) of these
women had their baseline mammogram at a facility that stopped participating in data
collection efforts prior to the woman turning age 45. This did not appear to vary
differentially by race/ethnicity (Hispanic 52.5%, white 51.9%, AA 53.7%) except for Asian
women (27.1%). We note, too, that women within BCSC registries can attend multiple
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facilities, so the closing of one facility does not necessarily mean the woman is lost to future
observation within a BCSC registry. We examined this issue by assigning mammography
facilities to “clusters”, i.e. groups of facilities that appear to cover similar catchment areas.
To do this we first identified women in the broader BCSC data who visit multiple different
facilities for screening mammography over a relatively short window of time (5 years). We
then assumed that multiple facilities being attended by a single woman likely cover
overlapping areas and thus might reasonably be able to serve common sets of women.
Considering ‘clusters’ of facilities that a woman may reasonably attend within each of the
given BCSC registries, only approximately 2% of the aforementioned 4,692 women had
their cluster of facilities end participation prior to their turning age 45.
AA race/ethnicity was associated with an increased risk of delayed age at first routine
screening mammography between ages 40-45. That we did not find an interaction in our
model suggests there is no significant racial/ethnic variability in the effect of the baseline
result on the timing of future mammography among women who return to a BCSC facility
for future screening between ages 40-45. We cannot know from these data why AA women
were at greater risk for a delay in the age of their future mammogram. However, it is
important to note the presence of such disparities so early in the screening lifetime. In
women 40 and older, the proportion and rates of advanced-stage cancer are similar across
racial and ethnic groups after accounting for variations in mammography screening.(10)
Improved adherence to recommended screening intervals may reduce the prevalence of
advanced-stage disease and resulting mortality rates.(10) Therefore, these findings generate
important avenues for future disparities work, including: examination of life-long
mammography use patterns; whether delays in mammography timing increase between
screening intervals; and the implications of an individualized, tailored approach to decision-
making at mammography initiation in consistency of care.
While ours is the first known study to examine the impact of racial/ethnic and baseline result
differences on subsequent mammography use, these findings should be considered in the
context of limitations. First, of the 31% who did not have future BCSC mammography
between ages 40-45, we do not know whether those women had a mammogram outside our
data capture area or if they simply did not have future mammography. Earlier in the
discussion we noted that approximately half of those who did not have future BCSC
mammography had their baseline mammogram at a facility that stopped participating in data
collection efforts prior to the woman turning age 45. Even though those women had
opportunity to attend other facilities within their registries, this does not preclude the
possibility that the association seen for our first outcome of interest might be explained by
differences across racial/ethnic groups in women’s interest or ability in attending different
BCSC mammography facilities. We recognize this as an important limitation of our study.
To provide some estimate of migration, if we examine the 20,192 women in our sample who
did have future BCSC mammography, 74.9% were seen for a mammogram after age 40 at
the same facility as their baseline mammogram; this percentage varied minimally across
racial/ethnic groups and FP/TN results (72.2-75.8%) with the exception of Hispanic women
(64.9%). Further research is needed to understand whether Hispanic women tend to have
different patient behaviors, live in more isolated areas and therefore depend on certain
clinics, or are more transient. Second, while we did not find a significant interaction between
race/ethnicity and baseline mammography results in either of our models, the possibility of
inadequate statistical power to detect these interactions should be considered. While these
data are among the best available for this purpose, by nature of the research question the cell
sizes become rather modest when examining these interactions, particularly among the non-
white FP groups. Related to this point, women who had a baseline mammogram at age 39
who had a diagnostic mammogram after age 40 would not have been included in our second
analysis of delay in timing of future screening, and so may be underrepresented. We
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encourage additional work to confirm a non-significant interaction between race/ethnicity
and baseline results on future mammography behaviors. Third, because of the percentage of
missing data for education, we had limited ability to interpret its potential role as a mediator
on our main associations, i.e. where, with the addition of education in the model, Asian
women were at significantly decreased risk of delaying the age of their future screening
mammogram. Fourth, to adequately address the research question of the impact of baseline
mammography outcomes on long-term mammography use would require a defined cohort
followed for decades, and include multifaceted, detailed information on physician
recommendations, women’s screening preferences, migration, and risk. In the absence of
this, these data are perhaps the closest proxy, being rich in their ability to: describe
mammography use by race/ethnicity, distinguish screening from diagnostic mammography,
use clinical records as opposed to strictly self-report, and then follow women longitudinally.
CONCLUSIONS
Using the 1994-2008 Breast Cancer Surveillance Consortium data, we found that race/
ethnicity is differentially associated with having future BCSC mammography and the timing
of future mammography screening after age 40. Risk of not returning to one of our facilities
for mammography was greater among Hispanic women than non-Hispanic whites. Among
those who returned, African American race was associated with an increased risk of delayed
age at first screening mammography between ages 40-45 compared to non-Hispanic whites.
Neither of these results was modified by the baseline mammography result of FP/TN. These
findings introduce the need for research that examines disparities in lifetime mammography
use patterns from the initiation of mammography screening and what factors impact long-
term mammography use.
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Table 3
Log-Linear Model to Estimate the Association of Not Returning for Future Mammography and Age of Future
Screening Mammogram between 40-45
Not Returning for Future Mammography RR
(95% CI)*,†, ‡
Delayed Age of Future Mammography RR
(95% CI)*,†,§
Race/ethnicity
 NH AA 1.04 (0.98, 1.09) 1.26 (1.09, 1.45)
 Asian 0.67 (0.61, 0.74) 0.92 (0.78, 1.09)
 Hispanic 1.21 (1.13, 1.30) 1.17 (1.00, 1.36)
 NH white Referent Referent
Outcome of baseline mammogram
FP 0.89 (0.85, 0.95) 0.97 (0.85, 1.10)
TN Referent Referent
Model n 29,175 17,935
*
RR: relative risk; CI: confidence interval; NH: non-Hispanic; AA: African American
†
Adjusted for mammography registry site, age at baseline screening mammogram ages 35-39, rural/urban status at baseline, and whether additional
screening occurred before age 40
‡
Defined as not having a mammogram, compared to having one, captured in the BCSC data between ages 40-45, including screening, diagnostic,
or unknown mammograms
§
Defined as the first future screening mammogram between ages 40-45 among women who returned to a BCSC facility for mammography; ages
43-45 compared to 40-42
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